Docking for neglected diseases as community efforts

Computational Structural Biology: Methods and Applications

Volumn , Issue , 2008, Pages 683-704

  Podvinec, M ^a   Schwede, T ^a   Peitsch, M C ^b  

^a UNIVERSITY OF BASEL   (Switzerland)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

NEGLECTED DISEASE;

EID: 77649201281     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789812778789_0025     Document Type: Chapter

References (60)

1. Leban J, Baierl M, Mies J, et al. (2007) A novel class of potent NF-kappaB signaling inhibitors. Bioorg Med Chem Lett 17(21): 5858-5862.
2. Scarsi M, Podvinec M, Roth A, et al. (2007) Sulfonylureas and glinides exhibit peroxisome proliferator-activated receptor gamma activity: a combined virtual screening and biological assay approach. Mol Pharmacol 71(2): 398-406.
3. Vangrevelinghe E, Zimmermann K, Schoepfer J, et al. (2003) Discovery of a potent and selective protein kinase CK2 inhibitor by high-throughput docking. J Med Chem 46(13): 2656-2662.
4. Doman TN, McGovern SL, Witherbee BJ, et al. (2002) Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B. J Med Chem 45(11): 2213-2221.
5. Cavasotto CN, Orry AJ. (2007) Ligand docking and structure-based virtual screening in drug discovery. Curr Top Med Chem 7(10): 1006-1014.
6. McGann MR, Almond HR, Nicholls A, et al. (2003) Gaussian docking functions. Biopolymers 68(1): 76-90.
7. Morris GM, Goodsell DS, Halliday RS, et al. (1998) Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 19(14): 1639-1662.
8. Friesner RA, Murphy RB, Repasky MP, et al. (2006) Extra precision glide:docking and scoring incorporating a model of hydrophobic enclosure for proteinligand complexes. J Med Chem 49(21): 6177-6196.
9. Grosdidier A, Zoete V, Michielin O. (2007) EADock: docking of small molecules into protein active sites with a multiobjective evolutionary optimization. Proteins 67(4): 1010-1025.
10. Thorsteinsdottir HB, Schwede T, Zoete V, Meuwly M. (2006) How inaccuracies in protein structure models affect estimates of protein-ligand interactions:computational analysis of HIV-1 protease inhibitor binding. Protein Struct Funct Bioinform 65(2): 407-423.
11. Message Passing Interface Forum [http://www.mpi-forum.org]
12. Foster I, Kesselman C, Nick JM, Tuecke S. (2002) Grid services for distributed system integration. Computer 35(6): 37-46.
13. Foster I, Kesselman C, Tuecke S. (2001) The anatomy of the grid: enabling scalable virtual organizations. Int J High Perform Comput Appl 15(3): 200-222.
14. Eerola P, Ekelöf T, Ellert M, et al. (2006) Roadmap for the ARC grid middleware. In J Dongarra, K Madsen, J Wasniewski (eds.), Applied Parallel Computing State of the Art in Scientific Computing. Springer.
15. Laure E, Fisher SM, Frohner A, et al. (2006) Programming the grid with gLite. Comput Meth Sci Tech 12(1): 33-45.
16. Frey J, Tannenbaum T, Foster I, et al. (2002) Condor-G: a computation management agent for multi-institutional grids. Cluster Comput 5(3):237-246.
17. Foster I, Kesselman C. (1997) Globus: a metacomputing infrastructure toolkit. Int J Supercomp Appl High Perform Comput 11(2): 115-128.
18. Streit A, Erwin D, Lippert T, et al. (2005) UNICORE-from project results to production grids. In L Grandinetti (ed.), Grid Computing: The New Frontiers of High Performance Processing, pp. 357-376. Elsevier.
19. Univa UD [http://www.univaud.com]
20. Berkeley Open Infrastructure for Network Computing (BOINC) [http://boinc.berkeley.edu]
21. Anderson DP, Cobb J, Korpela E, et al. (2002) SETI@home-an experiment in public-resource computing. Commun Acm 45(11): 56-61.
22. SETI@HOME [http://setiathome.berkeley.edu]
23. Anderson DP. (2004): BOINC: a system for public-resource computing and storage. In: 5th IEEE/ACM International Workshop on Grid Computing. Pittsburgh, USA.
24. distributed.net [http://www.distributed.net/]
25. malariacontrol.net [http://www.malariacontrol.net/]
26. climateprediction.net [http://www.climateprediction.net/index.php]
27. lhc@home [http://lhcathome.cern.ch/lhcathome/]
28. Zagrovic B, Snow CD, Shirts MR, Pande VS. (2002) Simulation of folding of a small alpha-helical protein in atomistic detail using worldwide-distributed computing. J Mol Biol 323(5): 927-937.
29. Crossing the petaflop barrier [http://folding.typepad.com/news/2007/09/crossing-the-pe.html]
30. Foster I. (2005) Service-oriented science. Science 308(5723): 814-817.
31. Buetow KH. (2005) Cyberinfrastructure: empowering a "third way" in biomedical research. Science 308(5723): 821-824.
32. Podvinec M, Maffioletti S, Kunszt P, et al. (2006) The SwissBioGrid project:objectives, preliminary results and lessons learned. In 2nd IEEE International Conference on e-Science and Grid Computing (e-Science 2006). IEEE Computer Society Press, Amsterdam, The Netherlands.
33. Bohannon J. (2005) Distributed computing. Grassroots supercomputing. Science 308(5723): 810.
34. Bohannon J. (2005) Distributed computing. Grid sport: competitive crunching. Science 308(5723): 812.
35. Richards WG, Grant GH, Harrison KN. (2004) Combating bioterrorism with personal computers. J Mole Graph Model 22(6): 473-478.
36. Zhang W, Du X, Ma F, et al. (2006) (DDGrid: harness the full power of supercomputing systems. In Grid and Cooperative Computing Workshops: GCCW '06 Fifth International Conference on.
37. Lee HC, Salzemann J, Jacq N, et al. (2006) Grid-enabled high-throughput in silico screening against influenza a neuraminidase. IEEE Trans Nanobiosci 5(4): 288-295.
38. Richards WG. (2002) Virtual screening using grid computing: the screensaver project. Nat Rev Drug Discov 1(7): 551-555.
39. Chang MW, Lindstrom W, Olson AJ, Belew RK. (2007) Analysis of HIV wildtype and mutant structures via in silico docking against diverse ligand libraries. J Chem Inform Model 47(3): 1258-1262.
40. Croft SL. (2005) Public-private partnership: from there to here. Trans Roy Soc Trop Med Hyg 99: S9-S14.
41. Kasam V, Zimmermann M, Maass A, et al. (2007) Design of new plasmepsin inhibitors: a virtual high-throughput screening approach on the EGEE grid. J Chem Inform Model 47(5): 1818-1828.
42. Nwaka S, Hudson A. (2006) Innovative lead discovery strategies for tropical diseases. Nature Rev Drug Discor 5(11): 941-955.
43. Irwin JJ, Shoichet BK. (2005) ZINC-a free database of commercially available compounds for virtual screening. J Chem Inform Model 45(1): 177-182.
44. Gohlke H, Kiel C, Case DA. (2003) Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RaIGDS complexes. J Mol Biol 330(4): 891-913.
45. Huang DZ, Luthi U, Kolb P, et al. (2005) Discovery of cell-permeable nonpeptide inhibitors of beta-secretase by high-throughput docking and continuum electrostatics calculations. J Med Chem 48(16): 5108-5111.
46. Mukhopadhyay S, Kuhn RJ, Rossmann MG. (2005) A structural perspective of the Flavivirus life cycle. Nat Rev Microbiol 3(1): 13-22.
47. Padmanabhan R, Mueller N, Reichert E, et al. (2006) Multiple enzyme activities of flavivirus proteins. Novartis Found Symp 277: 74-84; discussion 84-76, 251-253.
48. Modis Y, Ogata S, Clements D, Harrison SC. (2004) Structure of the dengue virus envelope protein after membrane fusion. Nature 427(6972): 313-319.
49. Zhang Y, Zhang W, Ogata S, et al. (2004) Conformational changes of the flavivirus E glycoprotein. Structure 12(9): 1607-1618.
50. Luo D, Xu T, Hunke C, Gruber G, et al. (2007) Crystal structure of the NS3 protease-helicase from dengue virus. J Virol.
51. Shuman S. (2001) Structure, mechanism, and evolution of the mRNA capping apparatus. Prog Nucl Acid Res Mol Biol 66: 1-40.
52. Egloff MP, Benarroch D, Selisko B, et al. (2002) An RNA cap (nucleoside-2′-O-)-methyltransferase in the flavivirus RNA polymerase NS5: crystal structure and functional characterization. EMBO J 21(11): 2757-2768.
53. Benarroch D, Egloff MP, Mulard L, et al. (2004) A structural basis for the inhibition of the NS5 dengue virus mRNA 2′-O-methyltransferase domain by ribavirin 5′-triphosphate. J Biol Chem 279(34): 35638-35643.
54. Sanschagrin P., personal communication (2007).
55. DiMasi JA, Hansen RW, Grabowski HG. (2003) The price of innovation: new estimates of drug development costs. J Health Econ 22(2): 151-185.
56. Peitsch MC, Searls DB, Shapiro E, Ferguson N. (2006) Revolutionising medicine. In S Emmot, S Rison (eds.), Towards 2020 Science. Microsoft.
57. Lewis R, Ertl P, Jacoby E, et al. (2005) Computational chemistry at novartis. Chimia 59(7-8): 545-549.
58. Arnold K, Bordoli L, Kopp J, Schwede T. (2006) The SWISS-MODEL workspace: A web-based environment for protein structure homology modelling. Bioinformatics 22(2): 195-201.
59. Rezza G, Nicoletti L, Angelini R, et al. CHIKV study group. (2007) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&CmdShowDetailView&Te. Infection with chikungunya virus in Italy: an outbreak in a temperature region. Lancet 1 370(9620): 1840-1846.
60. Laferl H, Szell M, Bischof E, Wenisch C. (2006) Imported dengue fever in Austria 1990-2005. Travel Med Infect Dis 4(6): 319-323.